Comparing the effects of adding Vagifem and vaginal Premarin in increasing endometrial thickness and pregnancy rate in IVF patients whose endometrial thickness was not responsive to conventional regimens, in Shiraz.
Status: Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 14 Sep 2016
Price : $35 *
At a glance
- Drugs Conjugated estrogens (Primary) ; Estradiol (Primary) ; Estrogen
- Indications Female infertility
- Focus Pharmacodynamics
- 20 Jan 2014 According to Iranian Registry of Clinical Trials record, status changed from recruiting to active, no longer recruiting.
- 29 Nov 2013 Recruitment complete.
- 31 May 2013 Status changed from not yet recruiting to recruiting as reported by Iranian Registry of Clinical Trials.